The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA moves toward easing restrictions on certain peptides BioPharma Dive BPC 157 Banned: Key Facts on the Latest FDA Decision FDA issued its first warning letter to a dispenser (a medical spa) for violating the Drug Supply Chain Security Act (DSCSA), including failing to source products from authorized trading partners and FDA to Convene Expert Panel on Expanding Access to Peptides Amid Safety, Regulatory Debate AJMC